Infection and inflammation in patients on dialysis: An underlying contributor to anemia and epoetin alfa hyporesponse

被引：0
|
作者：
Breiterman-White, Randee [1 ]
机构：
[1] Vanderbilt Univ, Ctr Med, Nashville, TN 37232 USA
来源：
NEPHROLOGY NURSING JOURNAL | 2006年 / 33卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R47 [护理学];
学科分类号：
1011 ;
摘要：
Acute or chronic infections or inflammatory conditions can exacerbate anemia inpatients on dialysis. The primary goal is to identify and treat the underlying disorder, while minimizing the impact on hemoglobin (Hb) levels. Nurses can be instrumental in minimizing the impact of these conditions by monitoring the longitudinal trends in Hb levels, proactively assessing patients for inflammatory or infectious conditions, and intervening to resolve causative conditions and minimize the impact on anemia.
引用
收藏
页码：319 / 322
页数：4
相关论文
共 50 条
  • [1] Switching Epoetin Alfa and Epoetin Zeta in Patients with Renal Anemia on Dialysis: Posthoc Analysis
    Wiecek, Andrzej
    Ahmed, Islah
    Scigalla, Paul
    Koytchev, Rossen
    ADVANCES IN THERAPY, 2010, 27 (12) : 941 - 952
  • [2] Switching epoetin alfa and epoetin zeta in patients with Renal Anemia on Dialysis: Posthoc analysis
    Andrzej Więcek
    Islah Ahmed
    Paul Scigalla
    Rossen Koytchev
    Advances in Therapy, 2010, 27 : 941 - 952
  • [3] Epogen - Treatment of anemia in children undergoing dialysis - Epoetin alfa for injection
    不详
    FORMULARY, 2000, 35 (01) : 10 - 10
  • [4] Treatment of a unique anemia in patients with IDDM with epoetin alfa
    Rarick, MU
    Espina, BM
    Colley, DT
    Chrusoskie, A
    Gandara, S
    Feinstein, DI
    DIABETES CARE, 1998, 21 (03) : 423 - 426
  • [5] Epoetin alfa for treatment of anemia in HIV-infected patients
    Bellman, P
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2005, 39 (03) : 376 - 377
  • [6] Is Intravenous Ascorbic Acid an Effective And Safe Option for Increasing Hemoglobin Levels in Patients with a Hyporesponse To Epoetin Alfa?
    Kear, Tamara M.
    NEPHROLOGY NURSING JOURNAL, 2012, 39 (02) : 137 - 140
  • [7] Comparison of intraperitoneal and subcutaneous epoetin alfa in peritoneal dialysis patients
    Johnson, CA
    Wakeen, M
    Taylor, CA
    Zimmerman, SW
    Burkart, J
    Bhattacharya, A
    Kosorok, MR
    PERITONEAL DIALYSIS INTERNATIONAL, 1999, 19 (06): : 578 - 582
  • [8] Pharmacokinetics and pharmacodynamics of darbepoetin alfa and epoetin in patients undergoing dialysis
    Allon, M
    Kleininan, K
    Walczyk, M
    Kaupke, C
    Messer-Mann, L
    Olson, K
    Heatherington, AC
    Maroni, BJ
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2002, 72 (05) : 546 - 555
  • [9] Effect of anemia treatment with epoetin alfa or darbepoetin alfa on left ventricular mass in patients with chronic kidney disease not on dialysis in Japan.
    Suzuki, Makoto
    Akaishi, Makoto
    Hada, Yoshiyuki
    Hiroe, Michiaki
    Aonuma, Kazutaka
    Tsubakihara, Yoshiharu
    Akizawa, Tadao
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2007, 49 (09) : 67A - 67A
  • [10] Epoetin alfa therapy for patients with hematologic malignancies and mild anemia
    Straus, DJ
    CLINICAL LYMPHOMA, 2003, 4 : S13 - S17
12345